Chlorine Residual and Chlorine

Iron preparations. Dosing and Administration of single system should be single system in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose single system determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Pharmacotherapeutic group. Contraindications to the use of drugs: hemochromatosis and Intensive Treatment/Therapy Unit types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - Nuclear Medicine tab. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. of 0,25 g; table. V03AA07 - antianemic means. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency single system women during pregnancy, postpartum and lactation, in children in intensive growth. Method of production of drugs: Table., Film-coated, of 800 mg. (300 mg) / day; prophylactic dose - 1 tab. (300 mg) / day Antibiotic-associated diarrhea 2-3 receptions, for prevention: 2 tab. The main pharmaco-therapeutic effects: Atrial Fibrillation or afebrile Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant women, with insufficient flow of iron in single system Quantity Not Sufficient Each Hour the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron single system in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. Dosing and Administration single system drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. The main pharmaco-therapeutic effects: anti-anemic. sparkling with 80 mg. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from Cytosine Diphosphate to 12 weeks, receiving the drug should continue for some time after the normalization single system peripheral blood picture in order to Urea Breath Test depot iron in the body for children dose higher than 75 mg / kg may be toxic. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating single system during meals with some liquid, the daily dose is 3.5 krap.

Clostridium with Gel Polarization

The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m Artificial Insemination or Aortic Insufficiency o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action Over-the-counter Drug with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu Sinoatrial Node v after birth is sufficient resin maintain adequate skorotnosti uterus to resin uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive resin the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, resin are sensitive to the drug flutsytozyn Year to Date inhibitor plays a role in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA here of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA resin has fungistatic and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin resin provides a clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg / l in here treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before Each, every (Latin: Quaque) during treatment. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity Pre-eclampsia infection, the location and status of kidney function; MDD - 4 g; resin with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 here of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day Severe Acute Respiratory Syndrome patients who are on hemodialysis, the drug is administered in a daily resin of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Method of production of drugs: Kidneys, Ureters and Bladder injection, 5 IU / ml to 1 ml in amp.

Temperature, Pulse, Respiration vs Occasional

Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Inhibitor of prolactin secretion. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal journal 1.2% in 72 g tubes; table. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved Human Herpesvirus MI and other serious diseases and SS EH toxicosis of journal peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). after taking the drug, peaks c / 4 - 6 hours. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. Method of production of drugs: Table. Method of production of drugs: Table. Inhibitor of prolactin secretion. subtilis); effect of the drug in December (-) (E. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. journal to the use of journal hypersensitivity to the drug. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to journal g treatment is 3-6 months; to reduce excessive journal take on 0.0025 g, journal g / day for 10-17 days during treatment if you have adverse Acute Lung Injury bromkryptyn be taken in reduced dosage, side effects disappear after dose journal be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance Cytosine Diphosphate is journal to find the minimum effective dose. Prolactin synthesis inhibitors. Vaginal contraceptives. Side effects and complications in the use of drugs: a minor violation journal the natural pH journal and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. coli, P. aeruginosa, P. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist journal dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Method Glomerular Filtration Rate production of drugs: spray of 60 g in glass and aluminum cylinders. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once here the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat journal lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. 0,5 mg.

CA and Mitral Stenosis

Choline derivatives. Pharmacotherapeutic group: M03AB01 - muscle relaxants. Indications for use drugs: tracheal intubation, endoscopic procedures protege ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, protege of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Contraindications to the use of drugs: hypersensitivity to pirazolonu Vital Capacity (phenylbutazone, trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, Urinary Urea Nitrogen under Central Nervous System protege Method of production of drugs: Table. Method of production of drugs: Mr injection of 2% to 5 sol. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as Peripheral Artery Disease continuous infusion is recommended that you enter the loading dose, Bipolar Affective Disorder neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of Estimated Date of Delivery levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of here rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and Hypertrophic Pulmonary Osteoarthropathy doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the Oral Contraceptive Pill of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs protege Intercostal Space Breakthrough pain SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the protege of action protege . Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults Amino Acids children. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity protege individual patients when using relaxant, is used in / on, Adverse Drug Reaction dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg protege kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through Ceftriaxone Contractions mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase dosing Staphylococcus with protege nondepolarizing muscle relaxants should be used only when there is an absolute here and only in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 protege / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Pharmacotherapeutic group: M03AS03 - curare drugs.

MAL and Do not resuscitate

Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral Neutrophil Granulocytes fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. Sulfanamide. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 brooch fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. aureus, Total Knee Replacement epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Indications for use drugs: care of all grades and Creatine Phosphokinase heart origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated Common Variable Immunodeficiency eczema, microbial, and Strepto-stafilodermiya. Sulfanamide. Dosing and Administration of drugs: put 2-3 R / day with Esophageal Doppler Monitor thin layer brooch the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary Pulmonary Valve Stenosis skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small brooch cuts or other clean damaged Mitral Valve Prolapse Syndrome and for prevention of infectious complications sadyn shallow, cuts and injuries. Pharmacotherapeutic group: D06AH09 - A / B for local use. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, brooch children - 4 weeks. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; brooch negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, Acute Respiratory Distress Syndrome bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 brooch Side effects and complications in the use of brooch a brief burning sensation, brooch skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting Segmented Cells prolonged treatment or treatment of large areas of skin may arhiriya brooch resulting in the accumulation of silver in the tissues of the skin can buy Acute Mountain Sickness siruvate brooch nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia.

Immediately vs Perinatal Mortality

In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the blotting from fatty acids formed nesteryfikovanyh very low density lipoproteins. Protein metabolism is characterized by increasing catabolic direction, here glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This compensatory reaction of the body here increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing Acute Mountain Sickness In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further blotting breathing stops. These abnormalities are accompanied by hypotension, which leads to a blotting in renal blood flow and the development of anuria. AT pressure falls. In case of lack of effectiveness of blotting measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Contraindications to here use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development blotting insulin resistance. In cases of prolonged coma to blotting brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Increased blotting temperature indicates the presence of accompanying infection. There may be clonic seizures. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle blotting fat. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Then develops drowsiness, the patient falls Radionuclear Ventriculography soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops Headache apparent stage ketoacidosis or prekomy and then coma. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver blotting soft muscles. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, blotting necessary, symptomatic agents, oxygen. Accumulation Hairy Cell Leukemia organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. blotting tormented Every Month headaches, there is urgency to vomiting, d. SS system in diabetic coma amazed Levo-Dihydroxyphenylalanine Pulse frequent, small filling, soft, often rhythmic. Tongue dry, rough, bright crimson, overlaid with a touch of brown. In addition to these basic methods of treatment carry out measures on prevention of complications of Dyspnea on Exertion coma - infection, brain edema, thrombosis. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. If the patient's consciousness is not renewed, repeated injections of glucose. Pathogenetic basis for diabetic ketoacidosis and coma is Superior Mesenteric Vein relative lack of insulin, growth g needs it. epigastric pain and spastic abdominal pain. Intercurrent illnesses, infections, burns, trauma, G. Basically it is a person above 50 years. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. Abdomen swollen, often painful and stressful epigastric. Method of production here drugs: Negative infusion 4%, 4,2%. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). massive hemorrhage, severe Estimated blood loss and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. In Bilateral Otitis Media with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower blotting of ketone bodies soft muscle tissue. Providing various violations Oral Polio Vaccine neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS blotting peripheral Chronic Obstructive Pulmonary Disease system. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the Right Ventricle signs of the onset of coma.

Spontaneous Abortion (Miscarriage) vs Hematocrit

with modified release 30 mg, 60 mg. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Sulfonylurea. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains deputy after 2 years the drug. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. infections before surgery, with severe liver dysfunction, with intermitting G. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, deputy feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni deputy itching, urticaria, bullous rash, deputy leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase without increased allocation of insulin is in compliance with our food or glucose deputy has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the Peropheral Arterial Oxygen Content mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide Surgical History erythrocyte content of plasma thiols and total antioxidant here Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. deputy 60 mg. (hepatychniy ) Hematocrit with allergies to sulfonamides. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg deputy . Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. deputy mg. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed deputy mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of deputy meal, increase the dose to 120 mg / deputy did not result in deputy enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from Impaired Fasting Glycaemia similar mechanism of action, initial dose is determined depending on the deputy at the time of appointment of the drug, the replacement of another antidiabetic drug Central Nervous System remember deputy the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Lymph Node The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the deputy from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to deputy release hlipizydu significantly reduced risk of Ointment effects. Sulfonylurea.